Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (NYSE: HIMS) may finally be succeeding in cracking the code. The online telehealth platform focuses on …
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?
view original post